13 results on '"Vargas-Peláez, Claudia Marcela"'
Search Results
2. The state of the art of marine natural products in Colombia
- Author
-
Bautista, Claudia Andrea, primary, Puentes, Carlos Andrés, additional, Vargas-Peláez, Claudia Marcela, additional, Santos-Acevedo, Marison, additional, Ramos, Freddy A, additional, Gómez-León, Javier, additional, and Castellanos Hernández, Leonardo, additional
- Published
- 2022
- Full Text
- View/download PDF
3. Acciones judiciales que exigen tecnologías en salud en Brasil: una revisión sistemática de métodos mixtos
- Author
-
da Trindade, Monica Cristina Nunes, Peres, Kaite Cristiane, de Souza, Mariana Nascimento, Cardoso, Carolina Nogared, Orozco, Daniel Cobo, Vargas-Peláez, Claudia Marcela, and Farias, Mareni Rocha
- Subjects
Judicialização da saúde ,Acesso a Medicamentos Essenciais e Tecnologias em Saúde ,Acceso a Medicamentos Esenciales y Tecnologías Sanitarias ,Health's Judicialization ,Right to Health ,Brasil ,Judicialización de la Salud ,Derecho a la salud ,Access to Essential Medicines and Health Technologies ,Brazil ,Direito a Saúde - Abstract
Objectives: to know the profile and understand the context described in publications on the judicialization of access to health technologies in Brazil. Methods: this study drew on the Joanna Briggs Institute (JBI) methodology for mixed-methods systematic reviews as it allows the synthesis of different designs/types of study, thus helping managers in the health decision-making process. Five databases were consulted, and articles were included that presented data from lawsuits demanding health technologies from the SUS in Brazil, or that analyzed this phenomenon, published in Portuguese, English and Spanish, until 2019. The methodological quality was evaluated using the convergent segregated approach. The characterization of data from the studies and the analysis and integration of qualitative-quantitative evidence were conducted through realistic synthesis. Results: 27 studies were included in the review. A total of 76,666 lawsuits were identified in which some health technology was requested, mainly medicines (65%); most lawsuits had private legal representation (68%) and most lawsuits were against the states (65%). The most frequent judicialization analysis approaches were Positive Social (32%) and Negative Normative (32%), followed by 29% for the Positive Normative approach. The Social Negative approach (7%) was the least frequent. Conclusions: it was identified that there is quantitative evidence that supports qualitative evidence. These demonstrate that the Judiciary's lack of knowledge about health policies leads to an increase in health inequalities; to the promotion of state paternalism, as well as the fact that the increase in lawsuits explains the need to seek alternatives for accessing health technologies. Objetivos: conocer el perfil y comprender el contexto descrito en las publicaciones sobre la judicialización del acceso a tecnologías en salud en Brasil. Metodología: se utilizó la metodología de revisión sistemática de métodos mixtos propuesta por el Instituto Joanna Briggs (JBI) que permite sintetizar diferentes diseños/tipos de estudio y ayuda a los gestores en la toma de decisiones en salud. Se consultaron 5 bases de datos y se incluyeron artículos que presentaran datos de procesos judiciales que demandan tecnologías en salud del SUS en Brasil, o que analizaran este fenómeno, publicados en portugués, inglés y español, hasta 2019. La calidad metodológica fue evaluada con un enfoque convergente segregado. La caracterización de los datos de los estudios y el análisis e integración de la evidencia cuali-cuantitativa se realizó usando la síntesis realista. Resultados: 27 estudios fueron incluidos en la revisión. Se identificaron 76.666 procesos judiciales en que se solicitaba alguna tecnología en salud, en su mayoría medicamentos (65%); la mayoría de los procesos presentaron una representación jurídica privada (68%) y la mayoría de las acciones fue contra los estados (65%). Los enfoques de análisis de judicialización más frecuentes fueron Social Positivo (32%) y Normativo Negativo (32%), seguidos de 29% para el abordaje de Normativo Positivo. El abordaje Social Negativo (7%) fue el menos frecuente. Conclusiones: se identificó que existen evidencias cuantitativas que soportan las evidencias cualitativas. Estas demuestran que el desconocimiento del Poder Judicial sobre las políticas de salud lleva a un aumento de las desigualdades en salud; al fomento del paternalismo del Estado, así como que el aumento de acciones judiciales explica la necesidad de la búsqueda de alternativas para acceder a tecnologías en salud. Objetivos: conhecer o perfil e compreender o contexto descrito nas publicações sobre a judicialização do acesso às tecnologias em saúde no Brasil. Metodologia: foi utilizada a metodologia de revisão sistemática de métodos mistos, estabelecida pelo Instituto Joanna Briggs (JBI), que permite sintetizar diferentes desenhos/tipos de estudo e auxilia os gestores na tomada de decisão em saúde. Foram consultadas cinco bases de dados e incluídos artigos que apresentassem dados de processos judiciais demandando tecnologias em saúde do SUS no Brasil, ou que analisassem esse fenômeno, publicados em português, inglês e espanhol, até 2019. A qualidade metodológica foi avaliada com a abordagem convergente segregada. A caracterização dos dados dos estudos e a análise e integração das evidências qualitativos-quantitativas foram realizadas por meio da síntese realista. Resultados: 27 estudos foram incluídos na revisão. Foram identificados 76.666 processos judiciais em que foi solicitada alguma tecnologia em saúde, principalmente medicamentos (65%); a maioria dos processos apresentou representação legal privada (68%) e a maioria das ações foi contra os estados (65%). As abordagens de análise de judicialização mais frequentes foram Social Positiva (32%) e Normativa Negativa (32%), seguidas de 29% para a abordagem Normativa Positiva. A abordagem Social Negativa (7%) foi a menos frequente. Conclusões: identificou-se que há evidências quantitativas que sustentam as evidências qualitativas. Estes demonstram que o desconhecimento do Judiciário sobre as políticas de saúde leva ao aumento das desigualdades em saúde; à promoção do paternalismo estatal, bem como o fato de que o aumento das ações judiciais explica a necessidade de buscar alternativas de acesso às tecnologias em saúde.
- Published
- 2022
- Full Text
- View/download PDF
4. Ações judiciais que demandam tecnologias em saúde no Brasil: uma revisão sistemática de métodos mistos
- Author
-
Da Trindade, Monica Cristina Nunes, primary, Peres, Kaite Cristiane, additional, de Souza, Mariana Nascimento, additional, Cardoso, Carolina Nogared, additional, Orozco, Daniel Cobo, additional, Vargas-Peláez, Claudia Marcela, additional, and Farias, Mareni Rocha, additional
- Published
- 2022
- Full Text
- View/download PDF
5. Characterization of the import applications for unavailable vital medicines in 2016 and 2017 in Colombia
- Author
-
Olivares, Luz Andrea, Vargas-Peláez, Claudia Marcela, Lopez, Jose Julian, Rossi, Francisco, and Chacón-Garzón, María Fernanda
- Published
- 2022
- Full Text
- View/download PDF
6. Vacinas no Brasil: análise histórica do registro sanitário e a disponibilização no Sistema de Saúde
- Author
-
Peres, Kaite Cristiane, Buendgens, Fabíola Bagatini, Prates, Ediana Adriano, Bonetti, Norberto Rech, Soares, Luciano, Vargas-Peláez, Claudia Marcela, and Farias, Mareni Rocha
- Subjects
Agência Nacional de Vigilância Sanitária ,Vaccines ,Vacinas ,Produtos biológicos ,Brazilian Health RegulatoryAgency ,Biological products ,Public Health ,Saúde Pública - Abstract
Resumo Com a pandemia da COVID-19 e a importância das políticas públicas de proteção social, questões sanitaristas incluindo as imunizações se tornaram destaque. O estudo tem o objetivo de analisar a dinâmica dos registros sanitários de vacinas no país e as vacinas disponibilizadas por meio do Programa Nacional de Imunização (PNI), com destaque para o calendário vacinal no período entre 2004 e 2018. Realizou-se um estudo descritivo, documental e exploratório dos processos de registro sanitário na Agência Nacional de Vigilância Sanitária (Anvisa) e a incorporação dos produtos no PNI. Como base da pesquisa foram utilizados o banco de dados de registro sanitário disponibilizado pela Anvisa, a análise documental de publicações oficiais/normativas e os dados da literatura. Os dados demonstram a incorporação das vacinas no PNI, assim como um país com potencial industrial para a produção das vacinas, no entanto ainda centrado na transferência de tecnologias, necessitando de investimentos e atenção pública no desenvolvimento de novas tecnologias, garantindo a independência do setor. Abstract Given the COVID-19 pandemic and the importance of public social protection policies, health issues, including immunizations, have gained prominence. This paper aims to analyze the dynamics of vaccine registration in Brazil and the vaccines made available through the National Immunization Program (PNI in Portuguese), with emphasis on the 2004-2018 vaccination schedule. This descriptive, exploratory, documentary research analyzed vaccine registration procedureswith the Brazilian Health Regulatory Agency (ANVISA, in Portuguese) and the incorporation of vaccine products into the PNI. The study drew on information from the national sanitary registration database, made available by ANVISA; a document analysis of official/normative publications; and data from published literature. The data shows the incorporation of vaccines into the PNI, evidencing that Brazil is a country with industrial potential for vaccine production but that is still focused on the transfer of technologies and in need of public attention and investments for developing new technologies as a way to ensure the sector’s independence.
- Published
- 2021
7. Vacinas no Brasil: análise histórica do registro sanitário e a disponibilização no Sistema de Saúde
- Author
-
Peres, Kaite Cristiane, primary, Buendgens, Fabíola Bagatini, additional, Prates, Ediana Adriano, additional, Bonetti, Norberto Rech, additional, Soares, Luciano, additional, Vargas-Peláez, Claudia Marcela, additional, and Farias, Mareni Rocha, additional
- Published
- 2021
- Full Text
- View/download PDF
8. Acesso a medicamentos de alto preço: desigualdades na organização e resultados entre estados brasileiros
- Author
-
Rover, Marina Raijche Mattozo, primary, Faraco, Emília Baierle, additional, Vargas-Peláez, Claudia Marcela, additional, Colussi, Claudia Flemming, additional, Storpirtis, Sílvia, additional, Farias, Mareni Rocha, additional, and Leite, Silvana Nair, additional
- Published
- 2021
- Full Text
- View/download PDF
9. Caracterización de las solicitudes de importación de medicamentos vitales no disponibles años 2016 y 2017 en Colombia
- Author
-
Olivares, Luz Andrea, primary, Vargas-Peláez, Claudia Marcela, additional, Lopez, Jose Julian, additional, Rossi, Francisco, additional, and Chacón-Garzón, María Fernanda, additional
- Published
- 2021
- Full Text
- View/download PDF
10. Barreras en el acceso a la atención en salud percibidas por parte de poblaciones vulnerables al VIH y/o VHC en el marco de la pandemia COVID-19 en Colombia
- Author
-
Mesa Ariza, Duvan Felipe, Vargas Peláez, Claudia Marcela, and Fundación Ifarma
- Subjects
Servicios de Salud ,Acceso a servicios de salud ,COVID-19 ,VIH ,HIV ,Enfermedades Transmisibles ,Health Services ,Colombia ,614 - Medicina Forense ,incidencia de lesiones, heridas, enfermedades ,medicina preventiva pública [610 - Medicina y salud] ,Vulnerable Populations ,Communicable Diseases ,Hepatitis C ,Health Services Accessibility ,Poblaciones Vulnerables ,Quality of Life ,Calidad de Vida - Abstract
ilustraciones, diagramas Antecedentes: Desde que la COVID-19 fue declarada una pandemia por la Organización Mundial de la Salud (OMS) en marzo de 2020, han sido necesarias una serie de medidas de prevención para frenar el contagio causado por la misma. Estas medidas han llevado a una disrupción de servicios sin precedentes en la sociedad, con consecuencias a nivel económico, social y en salud, exacerbando las disparidades existentes en la materia y profundizando las inequidades entre grupos marginalizados, tales disparidades e inequidades pueden tener consecuencias severas a mediano y largo plazo, especialmente en enfermedades transmisibles y patologías crónicas como el VIH y VHC. Objetivo: Analizar las barreras de acceso a la atención en salud percibidas por parte de poblaciones vulnerables al VIH y/o VHC en el marco de la pandemia COVID-19 en Colombia. Metodología: Se aplicaron encuestas en línea o en papel a personas mayores de edad y que se identificaron como pertenecientes a un grupo considerado vulnerable al VIH y/o VHC o que ya vivan con VIH y/o VHC en 7 ciudades siguiendo un muestreo no probabilístico. Resultados: Se recolectaron 462 cuestionarios, de los cuales 436 fueron incluidos en el análisis. Se encontró una disminución en la percepción de acceso a las herramientas y/o servicios de prevención y diagnóstico en el 20% de los participantes (n=89), para el caso de los tratamientos dicha reducción se presentó en el 14% de los participantes (n=59) y para las herramientas y/o servicios de reducción de daños esta reducción correspondió al 6% de los participantes (n=24); vivir con VIH, haber experimentado una peor calidad de vida con respecto al periodo anterior a la pandemia y haber estado en confinamiento durante uno o más periodos fueron asociados significativamente con una menor percepción de acceso a los servicios de salud, de manera contraria, tener estudios superiores fue asociado de manera significativa con una mayor percepción de acceso a estos servicios; la principal barrera identificada correspondió al cierre de los servicios de salud. Conclusiones: Esta investigación muestra el impacto causado por la pandemia de COVID-19 sobre el acceso a los servicios de salud a la vez que identifica las barreras presentadas y resalta la necesidad de desarrollar políticas públicas que además de responder a la crisis actual y las venideras, tenga en cuenta las necesidades de estas poblaciones vulnerables, de tal manera que dichas políticas promuevan la reducción de las inequidades y disparidades existentes en el acceso a los servicios de salud. (Texto tomado de la fuente) Background: Since COVID-19 was declared a pandemic by the World Health Organization (WHO) in March 2020, a series of preventive measures have been necessary to reduce the spread caused by it. These measures have led to an unprecedented disruption of services in society, with economic, social and health consequences, exacerbating existing disparities in this area and deepening inequities among marginalized groups. These disparities and inequities may have serious consequences in medium and long term, especially in communicable diseases and chronic pathologies such as HIV and HCV. Objective: Analyse the barriers to access to health care perceived by populations vulnerable to HIV and/or HCV in the framework of the COVID-19 pandemic in Colombia. Methods: Online or paper surveys were applied to people of legal age who identify themselves as belonging to a group considered vulnerable to HIV and/or HCV or who already live with HIV and/or HCV in seven cities following a non-probabilistic sampling. Results: 462 questionnaires were collected, of which 436 were included in the analysis. A decrease in the perception of access to prevention and diagnostic tools and/or services was found in 20% of the participants (n=89), in the case of treatments, this reduction occurred in 14% of the participants (n=59) and for harm reduction tools and/or services this reduction corresponded to 6% of the participants (n=24); living with HIV, having experienced a worse quality of life compared to the period before the pandemic and having been in confinement for one or more periods were significantly associated with a lower perception of access to health services, on the contrary, having studies superiors was significantly associated with a higher perception of access to these services; the main barrier identified corresponded to the closure of health services. Conclusions: This research shows the impact caused by the COVID-19 pandemic on health care access while identifying the barriers presented and highlights the need to develop public policies that, in addition to responding to the current and future crises, consider the needs of these vulnerable populations, so such policies promote the reduction of existing inequities and disparities in access to health services. Maestría Magíster en Ciencias - Farmacología Se aplicaron encuestas en línea o en papel a personas mayores de edad y que se identificaron como pertenecientes a un grupo considerado vulnerable al VIH y/o VHC o que ya vivan con VIH y/o VHC en 7 ciudades siguiendo un muestreo no probabilístico. Farmacoepidemiología
- Published
- 2022
11. Vaccines in Brazil: historical analysis of the Sanitary registration and vaccine availability in the Brazilian Unified Health System.
- Author
-
Peres KC, Buendgens FB, Prates EA, Bonetti NR, Soares L, Vargas-Peláez CM, and Farias MR
- Subjects
- Brazil, Humans, Pandemics, SARS-CoV-2, COVID-19, Vaccines
- Abstract
Given the COVID-19 pandemic and the importance of public social protection policies, health issues, including immunizations, have gained prominence. This paper aims to analyze the dynamics of vaccine registration in Brazil and the vaccines made available through the National Immunization Program (PNI in Portuguese), with emphasis on the 2004-2018 vaccination schedule. This descriptive, exploratory, documentary research analyzed vaccine registration procedureswith the Brazilian Health Regulatory Agency (ANVISA, in Portuguese) and the incorporation of vaccine products into the PNI. The study drew on information from the national sanitary registration database, made available by ANVISA; a document analysis of official/normative publications; and data from published literature. The data shows the incorporation of vaccines into the PNI, evidencing that Brazil is a country with industrial potential for vaccine production but that is still focused on the transfer of technologies and in need of public attention and investments for developing new technologies as a way to ensure the sector's independence.
- Published
- 2021
- Full Text
- View/download PDF
12. Characterization of the import applications for unavailable vital medicines in 2016 and 2017 in Colombia.
- Author
-
Olivares LA, Vargas-Peláez CM, Lopez JJ, Rossi F, and Chacón-Garzón MF
- Subjects
- Colombia, Humans, Government Programs, Rare Diseases
- Abstract
This study analyzed the import applications for unavailable vital medicines (MVND) submitted to INVIMA and the records of MVND reimbursement requests submitted to the ADRES in the 2016-2017 period. Approximately 76% of the 2,321 MVND import applications were authorized. Eighty-eight applicants, 73 therapeutic subgroups, 195 active ingredients, and 368 diagnoses were identified. Most of the patients registered in the import applications (66%) are linked to the contributory regime, to a lesser extent to the subsidized regime and the Special or exceptional regimes. The total value of the reimbursement requests related to MVND granted by lawsuits, was USD 8,577,583, equivalent to 38,483 UPCs. The results showed that the implementation of Decree N° 481/2004 has ensured access to medicines for rare diseases. However, it is not alien to the structural inequality of access to health services and medicines of the Colombian Health System, which impacts public health and the allocated budget, either because of the high cost of importing MVND or because of the lack of MVND regulation within the national market.
- Published
- 2021
- Full Text
- View/download PDF
13. Access to high-priced medicines: inequalities in the organization and the results among Brazilian states.
- Author
-
Rover MRM, Faraco EB, Vargas-Peláez CM, Colussi CF, Storpirtis S, Farias MR, and Leite SN
- Subjects
- Brazil, Health Services Accessibility, Health Surveys, Humans, Organizations, Socioeconomic Factors, Workforce, Pharmaceutical Services
- Abstract
This case study aimed to characterize the Specialized Component of Pharmaceutical Services (CEAF) organization in four Brazilian states from diverse regions of the country. Data were collected with representatives of CEAF management from states in different regions, who answered a 21-question questionnaire on scope, organization, financing, hurdles, and facilitators. This information was complemented with data from national health surveys, DataSUS, the applied resources, and socioeconomic indicators. Differences were observed between states on issues such as the proportion of users and the decentralization of services. These characteristics seem to be related to the level of development concerning the socioeconomic indicators used. Advances in access to medicines were highlighted, despite the difficulties complying with the CEAF's objectives, such as insufficient resources, the qualification of human resources, and the provision of necessary visits and exams. The results point to advances, different forms of organization and highlight the need for more in-depth studies on the clinical and economic outcomes achieved as a strategy to outline solutions to achieve the comprehensive and equal care for users.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.